Terms: = Uterine cancer AND RARA, RAR, 5914, ENSG00000131759, NR1B1 AND Treatment
19 results:
1. Targeting the Retinoic Acid Pathway to Eradicate cancer Stem Cells.
Brown G
Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768694
[TBL] [Abstract] [Full Text] [Related]
2. Retinoic acid receptor-beta prevents cisplatin-induced proximal tubular cell death.
Yago-Ibáñez J; García-Pastor C; Lucio-Cazaña FJ; Fernández-Martínez AB
Biochim Biophys Acta Mol Basis Dis; 2020 Jul; 1866(7):165795. PubMed ID: 32278009
[TBL] [Abstract] [Full Text] [Related]
3. Retinoic Acid Receptor β: A Potential Therapeutic Target in Retinoic Acid treatment of Endometrial cancer.
Tsuji K; Utsunomiya H; Miki Y; Hanihara M; Fue M; Takagi K; Nishimoto M; Suzuki F; Yaegashi N; Suzuki T; Ito K
Int J Gynecol Cancer; 2017 May; 27(4):643-650. PubMed ID: 28375930
[TBL] [Abstract] [Full Text] [Related]
4. rar-beta expression is associated with early volumetric changes to radiation therapy in cervical cancer.
Kim WY; Lee JW; Park YA; Choi JJ; Sung CO; Song SY; Choi CH; Kim TJ; Huh SJ; Kim BG; Bae DS
Gynecol Obstet Invest; 2011; 71(1):11-8. PubMed ID: 21160189
[TBL] [Abstract] [Full Text] [Related]
5. The cleavage fragment of retinoid X receptor-alpha ligand binding domain inhibits radiosensitization by retinoic acid.
Cho YM; Yang AH; Kim BY; Han YH
Oncol Rep; 2010 Jun; 23(6):1715-20. PubMed ID: 20428830
[TBL] [Abstract] [Full Text] [Related]
6. Expression of retinoic acid receptors in human endometrial carcinoma.
Tanabe K; Utsunomiya H; Tamura M; Niikura H; Takano T; Yoshinaga K; Nagase S; Suzuki T; Ito K; Matsumoto M; Hayashi S; Yaegashi N
Cancer Sci; 2008 Feb; 99(2):267-71. PubMed ID: 18271925
[TBL] [Abstract] [Full Text] [Related]
7. [Relationship between rar-beta gene expression defect and its methylation].
Gao YP; Li M; Zhang YY; Wang H; He XH; Wang ZH
Zhonghua Fu Chan Ke Za Zhi; 2007 Jul; 42(7):472-6. PubMed ID: 17961338
[TBL] [Abstract] [Full Text] [Related]
8. Retinoic acid signaling through PI 3-kinase induces differentiation of human endometrial adenocarcinoma cells.
Carter CA
Exp Mol Pathol; 2003 Aug; 75(1):34-44. PubMed ID: 12834623
[TBL] [Abstract] [Full Text] [Related]
9. Sensitivity of human tumor cells to retinoids or combined treatment with retinoids and ionizing radiation is not dependent on rar-beta 2 induction.
Blaese MA; Santo-Hoeltje L; Rodemann HP
Strahlenther Onkol; 2003 Jun; 179(6):401-9. PubMed ID: 12789467
[TBL] [Abstract] [Full Text] [Related]
10. Reactivation of tumor suppressor genes by the cardiovascular drugs hydralazine and procainamide and their potential use in cancer therapy.
Segura-Pacheco B; Trejo-Becerril C; Perez-Cardenas E; Taja-Chayeb L; Mariscal I; Chavez A; Acuña C; Salazar AM; Lizano M; Dueñas-Gonzalez A
Clin Cancer Res; 2003 May; 9(5):1596-603. PubMed ID: 12738711
[TBL] [Abstract] [Full Text] [Related]
11. Divergent effects of retinoic acids on the expression of ERalpha and 17beta-hydroxysteroid dehydrogenase type 2 in endometrial carcinoma cells (RL 95-2).
Li XH; Li H; Xiao ZJ; Piao YS
J Clin Endocrinol Metab; 2002 Feb; 87(2):640-9. PubMed ID: 11836298
[TBL] [Abstract] [Full Text] [Related]
12. Related case report: in vivo suppression of thyrotropin by 9-cis retinoic acid.
Dabon-Almirante CL; Damle S; Wadler S; Hupart K
Cancer J Sci Am; 1999; 5(3):171-3. PubMed ID: 10367174
[TBL] [Abstract] [Full Text] [Related]
13. The effect of all-trans and 9-cis retinoic acid on the steady state level of HPV16 E6/E7 mRNA and cell cycle in cervical carcinoma cells.
Narayanan BA; Holladay EB; Nixon DW; Mauro CT
Life Sci; 1998; 63(7):565-73. PubMed ID: 9718082
[TBL] [Abstract] [Full Text] [Related]
14. Biological assay for activity and molecular mechanism of retinoids in cervical tumor cells.
Benbrook DM; Lu S; Flanagan C; Shen-Gunther J; Angros LH; Lightfoot SA
Gynecol Oncol; 1997 Jul; 66(1):114-21. PubMed ID: 9234931
[TBL] [Abstract] [Full Text] [Related]
15. The additive antiproliferative effect of all-trans retinoic acid and interferon-alpha2a on human cervical carcinoma cell lines is not associated with increased expression of retinoid receptors.
Wahlberg P; Einarsdottir M; Fex G; Rydell R
Anticancer Drugs; 1997 Jun; 8(5):522-8. PubMed ID: 9215617
[TBL] [Abstract] [Full Text] [Related]
16. Discovery of novel retinoic acid receptor agonists having potent antiproliferative activity in cervical cancer cells.
Zhang L; Nadzan AM; Heyman RA; Love DL; Mais DE; Croston G; Lamph WW; Boehm MF
J Med Chem; 1996 Jul; 39(14):2659-63. PubMed ID: 8709094
[TBL] [Abstract] [Full Text] [Related]
17. Differential regulation of human ectocervical epithelial cell line proliferation and differentiation by retinoid X receptor- and retinoic acid receptor-specific retinoids.
Agarwal C; Chandraratna RA; Teng M; Nagpal S; Rorke EA; Eckert RL
Cell Growth Differ; 1996 Apr; 7(4):521-30. PubMed ID: 9052993
[TBL] [Abstract] [Full Text] [Related]
18. Detection of nuclear retinoic acid receptor mRNA in histological tissue sections using nonradioactive in situ hybridization histochemistry.
Xu XC; Clifford JL; Hong WK; Lotan R
Diagn Mol Pathol; 1994 Jun; 3(2):122-31. PubMed ID: 7520332
[TBL] [Abstract] [Full Text] [Related]
19. Retinoic acid-mediated repression of human papillomavirus 18 transcription and different ligand regulation of the retinoic acid receptor beta gene in non-tumorigenic and tumorigenic HeLa hybrid cells.
Bartsch D; Boye B; Baust C; zur Hausen H; Schwarz E
EMBO J; 1992 Jun; 11(6):2283-91. PubMed ID: 1318198
[TBL] [Abstract] [Full Text] [Related]
